Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Vaudry

Showing results (321-330 of 333) with videos related to

Pageof 34
Sort By:
International Journal of Cancer|November 16, 2005
Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytomaJohann Guillemot, Youssef Anouar, Maïté Montero-Hadjadje, et al.
The Journal of Clinical Endocrinology and Metabolism|September 20, 2007
Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancyErwan Thouënnon, Abdel G Elkahloun, Johann Guillemot, et al.
Cellular and Molecular Life Sciences : CMLS|December 22, 2017
Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's diseaseSeyma Bahdoudi, Ikram Ghouili, Mansour Hmiden, et al.
Plos One|March 26, 2015
PACAP enhances axon outgrowth in cultured hippocampal neurons to a comparable extent as BDNFKatsuya Ogata, Norihito Shintani, Atsuko Hayata-Takano, et al.
Neurobiology of Disease|March 1, 2014
tPA promotes ADAMTS-4-induced CSPG degradation, thereby enhancing neuroplasticity following spinal cord injurySighild Lemarchant, Mathilde Pruvost, Marie Hébert, et al.
Journal of Medicinal Chemistry|July 18, 2012
Rational design of a low molecular weight, stable, potent, and long-lasting GPR103 aza-β3-pseudopeptide agonistCindy Neveu, Benjamin Lefranc, Olivier Tasseau, et al.
Molecular Pharmacology|April 25, 2009
In vivo and in vitro structure-activity relationships and structural conformation of Kisspeptin-10-related peptidesEster Gutiérrez-Pascual, Jérôme Leprince, Antonio J Martínez-Fuentes, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2005
Differential effects of gonadotropin-releasing hormone (GnRH)-I and GnRH-II on prostate cancer cell signaling and deathKaushik Maiti, D Y Oh, Da Young Oh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapyEmilie Fauquembergue, Olivier Toutirais, David Tougeron, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 13, 2008
Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicityJose P Lopez-Atalaya, Benoit D Roussel, Denis Levrat, et al.
Pageof 34

Showing results (321-330 of 333) with videos related to

Sort By:
Pageof 34
International Journal of Cancer|November 16, 2005
Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytomaJohann Guillemot, Youssef Anouar, Maïté Montero-Hadjadje, et al.
The Journal of Clinical Endocrinology and Metabolism|September 20, 2007
Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancyErwan Thouënnon, Abdel G Elkahloun, Johann Guillemot, et al.
Cellular and Molecular Life Sciences : CMLS|December 22, 2017
Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's diseaseSeyma Bahdoudi, Ikram Ghouili, Mansour Hmiden, et al.
Plos One|March 26, 2015
PACAP enhances axon outgrowth in cultured hippocampal neurons to a comparable extent as BDNFKatsuya Ogata, Norihito Shintani, Atsuko Hayata-Takano, et al.
Neurobiology of Disease|March 1, 2014
tPA promotes ADAMTS-4-induced CSPG degradation, thereby enhancing neuroplasticity following spinal cord injurySighild Lemarchant, Mathilde Pruvost, Marie Hébert, et al.
Journal of Medicinal Chemistry|July 18, 2012
Rational design of a low molecular weight, stable, potent, and long-lasting GPR103 aza-β3-pseudopeptide agonistCindy Neveu, Benjamin Lefranc, Olivier Tasseau, et al.
Molecular Pharmacology|April 25, 2009
In vivo and in vitro structure-activity relationships and structural conformation of Kisspeptin-10-related peptidesEster Gutiérrez-Pascual, Jérôme Leprince, Antonio J Martínez-Fuentes, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2005
Differential effects of gonadotropin-releasing hormone (GnRH)-I and GnRH-II on prostate cancer cell signaling and deathKaushik Maiti, D Y Oh, Da Young Oh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapyEmilie Fauquembergue, Olivier Toutirais, David Tougeron, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 13, 2008
Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicityJose P Lopez-Atalaya, Benoit D Roussel, Denis Levrat, et al.
Pageof 34